Available to sourceHuman Prescription DrugGastrointestinal

SODIUM CHLORIDE

.9 mg/mL · Injection

By Liebel-Flarsheim Company LLC

NDC: 0019-1188
Route: Intravascular
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.